nodes	percent_of_prediction	percent_of_DWPC	metapath
Efavirenz—CYP2C19—Prednisone—psoriatic arthritis	0.0834	0.147	CbGbCtD
Efavirenz—CYP2B6—Dexamethasone—psoriatic arthritis	0.082	0.144	CbGbCtD
Efavirenz—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0666	0.117	CbGbCtD
Efavirenz—CYP2C19—Dexamethasone—psoriatic arthritis	0.0521	0.0915	CbGbCtD
Efavirenz—CYP3A4—Triamcinolone—psoriatic arthritis	0.0504	0.0887	CbGbCtD
Efavirenz—CYP2C9—Dexamethasone—psoriatic arthritis	0.0433	0.0761	CbGbCtD
Efavirenz—CYP3A4—Betamethasone—psoriatic arthritis	0.0433	0.0761	CbGbCtD
Efavirenz—CYP3A4—Prednisolone—psoriatic arthritis	0.0427	0.0751	CbGbCtD
Efavirenz—CYP3A4—Prednisone—psoriatic arthritis	0.0403	0.0709	CbGbCtD
Efavirenz—CYP2D6—Dexamethasone—psoriatic arthritis	0.0396	0.0696	CbGbCtD
Efavirenz—CYP3A4—Dexamethasone—psoriatic arthritis	0.0252	0.0443	CbGbCtD
Efavirenz—Discomfort—Methylprednisolone—psoriatic arthritis	0.000394	0.000914	CcSEcCtD
Efavirenz—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.000393	0.000913	CcSEcCtD
Efavirenz—Dry mouth—Triamcinolone—psoriatic arthritis	0.000391	0.000907	CcSEcCtD
Efavirenz—Renal failure—Methotrexate—psoriatic arthritis	0.00039	0.000905	CcSEcCtD
Efavirenz—Angioedema—Dexamethasone—psoriatic arthritis	0.000389	0.000903	CcSEcCtD
Efavirenz—Angioedema—Betamethasone—psoriatic arthritis	0.000389	0.000903	CcSEcCtD
Efavirenz—Angiopathy—Prednisone—psoriatic arthritis	0.000387	0.000897	CcSEcCtD
Efavirenz—Confusional state—Methylprednisolone—psoriatic arthritis	0.000386	0.000894	CcSEcCtD
Efavirenz—Immune system disorder—Prednisone—psoriatic arthritis	0.000385	0.000893	CcSEcCtD
Efavirenz—Malaise—Dexamethasone—psoriatic arthritis	0.000384	0.000891	CcSEcCtD
Efavirenz—Malaise—Betamethasone—psoriatic arthritis	0.000384	0.000891	CcSEcCtD
Efavirenz—Vertigo—Dexamethasone—psoriatic arthritis	0.000383	0.000888	CcSEcCtD
Efavirenz—Vertigo—Betamethasone—psoriatic arthritis	0.000383	0.000888	CcSEcCtD
Efavirenz—Syncope—Dexamethasone—psoriatic arthritis	0.000382	0.000886	CcSEcCtD
Efavirenz—Syncope—Betamethasone—psoriatic arthritis	0.000382	0.000886	CcSEcCtD
Efavirenz—Arrhythmia—Prednisone—psoriatic arthritis	0.000381	0.000883	CcSEcCtD
Efavirenz—Sweating—Methotrexate—psoriatic arthritis	0.00038	0.000882	CcSEcCtD
Efavirenz—Haematuria—Methotrexate—psoriatic arthritis	0.000378	0.000878	CcSEcCtD
Efavirenz—Shock—Triamcinolone—psoriatic arthritis	0.000377	0.000875	CcSEcCtD
Efavirenz—Insomnia—Prednisolone—psoriatic arthritis	0.000377	0.000874	CcSEcCtD
Efavirenz—Alopecia—Prednisone—psoriatic arthritis	0.000377	0.000874	CcSEcCtD
Efavirenz—Shock—Methylprednisolone—psoriatic arthritis	0.000376	0.000873	CcSEcCtD
Efavirenz—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000375	0.000871	CcSEcCtD
Efavirenz—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000375	0.00087	CcSEcCtD
Efavirenz—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000374	0.000869	CcSEcCtD
Efavirenz—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000374	0.000869	CcSEcCtD
Efavirenz—Paraesthesia—Prednisolone—psoriatic arthritis	0.000374	0.000868	CcSEcCtD
Efavirenz—Tachycardia—Triamcinolone—psoriatic arthritis	0.000374	0.000868	CcSEcCtD
Efavirenz—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000373	0.000866	CcSEcCtD
Efavirenz—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000371	0.000862	CcSEcCtD
Efavirenz—Malnutrition—Prednisone—psoriatic arthritis	0.000371	0.000861	CcSEcCtD
Efavirenz—Erythema—Prednisone—psoriatic arthritis	0.000371	0.000861	CcSEcCtD
Efavirenz—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000371	0.000859	CcSEcCtD
Efavirenz—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00037	0.000857	CcSEcCtD
Efavirenz—Convulsion—Betamethasone—psoriatic arthritis	0.000369	0.000856	CcSEcCtD
Efavirenz—Convulsion—Dexamethasone—psoriatic arthritis	0.000369	0.000856	CcSEcCtD
Efavirenz—Hypertension—Betamethasone—psoriatic arthritis	0.000368	0.000853	CcSEcCtD
Efavirenz—Hypertension—Dexamethasone—psoriatic arthritis	0.000368	0.000853	CcSEcCtD
Efavirenz—Myalgia—Dexamethasone—psoriatic arthritis	0.000363	0.000841	CcSEcCtD
Efavirenz—Myalgia—Betamethasone—psoriatic arthritis	0.000363	0.000841	CcSEcCtD
Efavirenz—Anxiety—Betamethasone—psoriatic arthritis	0.000361	0.000839	CcSEcCtD
Efavirenz—Anxiety—Dexamethasone—psoriatic arthritis	0.000361	0.000839	CcSEcCtD
Efavirenz—Discomfort—Betamethasone—psoriatic arthritis	0.000358	0.000831	CcSEcCtD
Efavirenz—Discomfort—Dexamethasone—psoriatic arthritis	0.000358	0.000831	CcSEcCtD
Efavirenz—Pain—Prednisolone—psoriatic arthritis	0.000356	0.000827	CcSEcCtD
Efavirenz—Hepatitis—Methotrexate—psoriatic arthritis	0.000356	0.000826	CcSEcCtD
Efavirenz—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000352	0.000816	CcSEcCtD
Efavirenz—Vision blurred—Prednisone—psoriatic arthritis	0.00035	0.000811	CcSEcCtD
Efavirenz—Urethral disorder—Methotrexate—psoriatic arthritis	0.000349	0.00081	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000349	0.00081	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000348	0.000808	CcSEcCtD
Efavirenz—Insomnia—Triamcinolone—psoriatic arthritis	0.000347	0.000804	CcSEcCtD
Efavirenz—Insomnia—Methylprednisolone—psoriatic arthritis	0.000346	0.000802	CcSEcCtD
Efavirenz—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000344	0.000799	CcSEcCtD
Efavirenz—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000344	0.000798	CcSEcCtD
Efavirenz—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000343	0.000797	CcSEcCtD
Efavirenz—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000343	0.000796	CcSEcCtD
Efavirenz—Visual impairment—Methotrexate—psoriatic arthritis	0.000343	0.000796	CcSEcCtD
Efavirenz—Anaemia—Prednisone—psoriatic arthritis	0.000343	0.000796	CcSEcCtD
Efavirenz—Shock—Betamethasone—psoriatic arthritis	0.000342	0.000794	CcSEcCtD
Efavirenz—Shock—Dexamethasone—psoriatic arthritis	0.000342	0.000794	CcSEcCtD
Efavirenz—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000342	0.000793	CcSEcCtD
Efavirenz—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000341	0.000791	CcSEcCtD
Efavirenz—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000341	0.000791	CcSEcCtD
Efavirenz—Agitation—Prednisone—psoriatic arthritis	0.000341	0.000791	CcSEcCtD
Efavirenz—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00034	0.00079	CcSEcCtD
Efavirenz—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00034	0.00079	CcSEcCtD
Efavirenz—Tachycardia—Dexamethasone—psoriatic arthritis	0.000339	0.000787	CcSEcCtD
Efavirenz—Tachycardia—Betamethasone—psoriatic arthritis	0.000339	0.000787	CcSEcCtD
Efavirenz—Angioedema—Prednisone—psoriatic arthritis	0.000339	0.000786	CcSEcCtD
Efavirenz—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000337	0.000783	CcSEcCtD
Efavirenz—Erythema multiforme—Methotrexate—psoriatic arthritis	0.000337	0.000781	CcSEcCtD
Efavirenz—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000337	0.000781	CcSEcCtD
Efavirenz—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000336	0.00078	CcSEcCtD
Efavirenz—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000336	0.00078	CcSEcCtD
Efavirenz—Malaise—Prednisone—psoriatic arthritis	0.000335	0.000776	CcSEcCtD
Efavirenz—Vertigo—Prednisone—psoriatic arthritis	0.000333	0.000773	CcSEcCtD
Efavirenz—Eye disorder—Methotrexate—psoriatic arthritis	0.000333	0.000772	CcSEcCtD
Efavirenz—Syncope—Prednisone—psoriatic arthritis	0.000333	0.000772	CcSEcCtD
Efavirenz—Tinnitus—Methotrexate—psoriatic arthritis	0.000332	0.00077	CcSEcCtD
Efavirenz—Anorexia—Betamethasone—psoriatic arthritis	0.000331	0.000769	CcSEcCtD
Efavirenz—Anorexia—Dexamethasone—psoriatic arthritis	0.000331	0.000769	CcSEcCtD
Efavirenz—Urticaria—Prednisolone—psoriatic arthritis	0.000331	0.000768	CcSEcCtD
Efavirenz—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000331	0.000767	CcSEcCtD
Efavirenz—Fatigue—Triamcinolone—psoriatic arthritis	0.00033	0.000766	CcSEcCtD
Efavirenz—Fatigue—Methylprednisolone—psoriatic arthritis	0.00033	0.000765	CcSEcCtD
Efavirenz—Pain—Triamcinolone—psoriatic arthritis	0.000328	0.00076	CcSEcCtD
Efavirenz—Loss of consciousness—Prednisone—psoriatic arthritis	0.000326	0.000756	CcSEcCtD
Efavirenz—Angiopathy—Methotrexate—psoriatic arthritis	0.000323	0.00075	CcSEcCtD
Efavirenz—Immune system disorder—Methotrexate—psoriatic arthritis	0.000322	0.000746	CcSEcCtD
Efavirenz—Convulsion—Prednisone—psoriatic arthritis	0.000322	0.000746	CcSEcCtD
Efavirenz—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000321	0.000745	CcSEcCtD
Efavirenz—Hypertension—Prednisone—psoriatic arthritis	0.00032	0.000743	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000317	0.000735	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000317	0.000735	CcSEcCtD
Efavirenz—Arthralgia—Prednisone—psoriatic arthritis	0.000316	0.000733	CcSEcCtD
Efavirenz—Myalgia—Prednisone—psoriatic arthritis	0.000316	0.000733	CcSEcCtD
Efavirenz—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000316	0.000733	CcSEcCtD
Efavirenz—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000315	0.000731	CcSEcCtD
Efavirenz—Anxiety—Prednisone—psoriatic arthritis	0.000315	0.00073	CcSEcCtD
Efavirenz—Alopecia—Methotrexate—psoriatic arthritis	0.000315	0.00073	CcSEcCtD
Efavirenz—Insomnia—Dexamethasone—psoriatic arthritis	0.000315	0.00073	CcSEcCtD
Efavirenz—Insomnia—Betamethasone—psoriatic arthritis	0.000315	0.00073	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000314	0.000728	CcSEcCtD
Efavirenz—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000313	0.000725	CcSEcCtD
Efavirenz—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000312	0.000724	CcSEcCtD
Efavirenz—Paraesthesia—Betamethasone—psoriatic arthritis	0.000312	0.000724	CcSEcCtD
Efavirenz—Discomfort—Prednisone—psoriatic arthritis	0.000312	0.000724	CcSEcCtD
Efavirenz—Malnutrition—Methotrexate—psoriatic arthritis	0.00031	0.000719	CcSEcCtD
Efavirenz—Erythema—Methotrexate—psoriatic arthritis	0.00031	0.000719	CcSEcCtD
Efavirenz—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000307	0.000712	CcSEcCtD
Efavirenz—Dyspepsia—Betamethasone—psoriatic arthritis	0.000306	0.00071	CcSEcCtD
Efavirenz—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000306	0.00071	CcSEcCtD
Efavirenz—Urticaria—Triamcinolone—psoriatic arthritis	0.000304	0.000706	CcSEcCtD
Efavirenz—Urticaria—Methylprednisolone—psoriatic arthritis	0.000304	0.000705	CcSEcCtD
Efavirenz—Dysgeusia—Methotrexate—psoriatic arthritis	0.000304	0.000704	CcSEcCtD
Efavirenz—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000303	0.000703	CcSEcCtD
Efavirenz—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000302	0.000701	CcSEcCtD
Efavirenz—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000302	0.000701	CcSEcCtD
Efavirenz—Decreased appetite—Betamethasone—psoriatic arthritis	0.000302	0.000701	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.0003	0.000696	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.0003	0.000696	CcSEcCtD
Efavirenz—Back pain—Methotrexate—psoriatic arthritis	0.0003	0.000696	CcSEcCtD
Efavirenz—Fatigue—Betamethasone—psoriatic arthritis	0.0003	0.000695	CcSEcCtD
Efavirenz—Fatigue—Dexamethasone—psoriatic arthritis	0.0003	0.000695	CcSEcCtD
Efavirenz—Shock—Prednisone—psoriatic arthritis	0.000298	0.000691	CcSEcCtD
Efavirenz—Pain—Dexamethasone—psoriatic arthritis	0.000297	0.00069	CcSEcCtD
Efavirenz—Pain—Betamethasone—psoriatic arthritis	0.000297	0.00069	CcSEcCtD
Efavirenz—Nervous system disorder—Prednisone—psoriatic arthritis	0.000297	0.000689	CcSEcCtD
Efavirenz—Tachycardia—Prednisone—psoriatic arthritis	0.000296	0.000686	CcSEcCtD
Efavirenz—Skin disorder—Prednisone—psoriatic arthritis	0.000294	0.000682	CcSEcCtD
Efavirenz—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000293	0.000679	CcSEcCtD
Efavirenz—Vision blurred—Methotrexate—psoriatic arthritis	0.000292	0.000678	CcSEcCtD
Efavirenz—Anorexia—Prednisone—psoriatic arthritis	0.000289	0.00067	CcSEcCtD
Efavirenz—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000288	0.000667	CcSEcCtD
Efavirenz—Anaemia—Methotrexate—psoriatic arthritis	0.000287	0.000665	CcSEcCtD
Efavirenz—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000287	0.000665	CcSEcCtD
Efavirenz—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000287	0.000665	CcSEcCtD
Efavirenz—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000284	0.00066	CcSEcCtD
Efavirenz—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000284	0.00066	CcSEcCtD
Efavirenz—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000282	0.000655	CcSEcCtD
Efavirenz—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000282	0.000653	CcSEcCtD
Efavirenz—Malaise—Methotrexate—psoriatic arthritis	0.00028	0.000649	CcSEcCtD
Efavirenz—Vertigo—Methotrexate—psoriatic arthritis	0.000279	0.000646	CcSEcCtD
Efavirenz—Urticaria—Betamethasone—psoriatic arthritis	0.000276	0.000641	CcSEcCtD
Efavirenz—Urticaria—Dexamethasone—psoriatic arthritis	0.000276	0.000641	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000276	0.00064	CcSEcCtD
Efavirenz—Dizziness—Prednisolone—psoriatic arthritis	0.000276	0.000639	CcSEcCtD
Efavirenz—Asthenia—Triamcinolone—psoriatic arthritis	0.000275	0.000638	CcSEcCtD
Efavirenz—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000275	0.000638	CcSEcCtD
Efavirenz—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000275	0.000638	CcSEcCtD
Efavirenz—Abdominal pain—Betamethasone—psoriatic arthritis	0.000275	0.000638	CcSEcCtD
Efavirenz—Body temperature increased—Betamethasone—psoriatic arthritis	0.000275	0.000638	CcSEcCtD
Efavirenz—Asthenia—Methylprednisolone—psoriatic arthritis	0.000274	0.000636	CcSEcCtD
Efavirenz—Insomnia—Prednisone—psoriatic arthritis	0.000274	0.000635	CcSEcCtD
Efavirenz—Paraesthesia—Prednisone—psoriatic arthritis	0.000272	0.000631	CcSEcCtD
Efavirenz—Pruritus—Triamcinolone—psoriatic arthritis	0.000271	0.000629	CcSEcCtD
Efavirenz—Cough—Methotrexate—psoriatic arthritis	0.000271	0.000628	CcSEcCtD
Efavirenz—Pruritus—Methylprednisolone—psoriatic arthritis	0.000271	0.000628	CcSEcCtD
Efavirenz—Convulsion—Methotrexate—psoriatic arthritis	0.000269	0.000623	CcSEcCtD
Efavirenz—Dyspepsia—Prednisone—psoriatic arthritis	0.000267	0.000618	CcSEcCtD
Efavirenz—Chest pain—Methotrexate—psoriatic arthritis	0.000264	0.000612	CcSEcCtD
Efavirenz—Arthralgia—Methotrexate—psoriatic arthritis	0.000264	0.000612	CcSEcCtD
Efavirenz—Myalgia—Methotrexate—psoriatic arthritis	0.000264	0.000612	CcSEcCtD
Efavirenz—Decreased appetite—Prednisone—psoriatic arthritis	0.000263	0.000611	CcSEcCtD
Efavirenz—Rash—Prednisolone—psoriatic arthritis	0.000263	0.00061	CcSEcCtD
Efavirenz—Dermatitis—Prednisolone—psoriatic arthritis	0.000263	0.000609	CcSEcCtD
Efavirenz—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000262	0.000608	CcSEcCtD
Efavirenz—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000262	0.000607	CcSEcCtD
Efavirenz—Fatigue—Prednisone—psoriatic arthritis	0.000261	0.000606	CcSEcCtD
Efavirenz—Headache—Prednisolone—psoriatic arthritis	0.000261	0.000606	CcSEcCtD
Efavirenz—Discomfort—Methotrexate—psoriatic arthritis	0.000261	0.000605	CcSEcCtD
Efavirenz—Constipation—Prednisone—psoriatic arthritis	0.000259	0.000601	CcSEcCtD
Efavirenz—Confusional state—Methotrexate—psoriatic arthritis	0.000255	0.000592	CcSEcCtD
Efavirenz—Dizziness—Triamcinolone—psoriatic arthritis	0.000253	0.000588	CcSEcCtD
Efavirenz—Dizziness—Methylprednisolone—psoriatic arthritis	0.000253	0.000587	CcSEcCtD
Efavirenz—Feeling abnormal—Prednisone—psoriatic arthritis	0.00025	0.000579	CcSEcCtD
Efavirenz—Asthenia—Dexamethasone—psoriatic arthritis	0.000249	0.000579	CcSEcCtD
Efavirenz—Asthenia—Betamethasone—psoriatic arthritis	0.000249	0.000579	CcSEcCtD
Efavirenz—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000248	0.000576	CcSEcCtD
Efavirenz—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000248	0.000575	CcSEcCtD
Efavirenz—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000248	0.000574	CcSEcCtD
Efavirenz—Nausea—Prednisolone—psoriatic arthritis	0.000248	0.000574	CcSEcCtD
Efavirenz—Pruritus—Betamethasone—psoriatic arthritis	0.000246	0.000571	CcSEcCtD
Efavirenz—Pruritus—Dexamethasone—psoriatic arthritis	0.000246	0.000571	CcSEcCtD
Efavirenz—Skin disorder—Methotrexate—psoriatic arthritis	0.000246	0.00057	CcSEcCtD
Efavirenz—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000245	0.000568	CcSEcCtD
Efavirenz—Vomiting—Triamcinolone—psoriatic arthritis	0.000244	0.000565	CcSEcCtD
Efavirenz—Vomiting—Methylprednisolone—psoriatic arthritis	0.000243	0.000564	CcSEcCtD
Efavirenz—Rash—Triamcinolone—psoriatic arthritis	0.000242	0.000561	CcSEcCtD
Efavirenz—Dermatitis—Triamcinolone—psoriatic arthritis	0.000241	0.00056	CcSEcCtD
Efavirenz—Anorexia—Methotrexate—psoriatic arthritis	0.000241	0.00056	CcSEcCtD
Efavirenz—Rash—Methylprednisolone—psoriatic arthritis	0.000241	0.000559	CcSEcCtD
Efavirenz—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000241	0.000559	CcSEcCtD
Efavirenz—Urticaria—Prednisone—psoriatic arthritis	0.000241	0.000558	CcSEcCtD
Efavirenz—Headache—Triamcinolone—psoriatic arthritis	0.00024	0.000557	CcSEcCtD
Efavirenz—Headache—Methylprednisolone—psoriatic arthritis	0.00024	0.000556	CcSEcCtD
Efavirenz—Body temperature increased—Prednisone—psoriatic arthritis	0.000239	0.000555	CcSEcCtD
Efavirenz—Abdominal pain—Prednisone—psoriatic arthritis	0.000239	0.000555	CcSEcCtD
Efavirenz—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000238	0.000552	CcSEcCtD
Efavirenz—Diarrhoea—Betamethasone—psoriatic arthritis	0.000238	0.000552	CcSEcCtD
Efavirenz—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000231	0.000535	CcSEcCtD
Efavirenz—Dizziness—Betamethasone—psoriatic arthritis	0.00023	0.000533	CcSEcCtD
Efavirenz—Dizziness—Dexamethasone—psoriatic arthritis	0.00023	0.000533	CcSEcCtD
Efavirenz—Insomnia—Methotrexate—psoriatic arthritis	0.000229	0.000531	CcSEcCtD
Efavirenz—Nausea—Triamcinolone—psoriatic arthritis	0.000228	0.000528	CcSEcCtD
Efavirenz—Paraesthesia—Methotrexate—psoriatic arthritis	0.000227	0.000527	CcSEcCtD
Efavirenz—Nausea—Methylprednisolone—psoriatic arthritis	0.000227	0.000527	CcSEcCtD
Efavirenz—Dyspnoea—Methotrexate—psoriatic arthritis	0.000226	0.000523	CcSEcCtD
Efavirenz—Somnolence—Methotrexate—psoriatic arthritis	0.000225	0.000522	CcSEcCtD
Efavirenz—Hypersensitivity—Prednisone—psoriatic arthritis	0.000223	0.000518	CcSEcCtD
Efavirenz—Dyspepsia—Methotrexate—psoriatic arthritis	0.000223	0.000517	CcSEcCtD
Efavirenz—Vomiting—Betamethasone—psoriatic arthritis	0.000221	0.000513	CcSEcCtD
Efavirenz—Vomiting—Dexamethasone—psoriatic arthritis	0.000221	0.000513	CcSEcCtD
Efavirenz—Decreased appetite—Methotrexate—psoriatic arthritis	0.00022	0.00051	CcSEcCtD
Efavirenz—Rash—Betamethasone—psoriatic arthritis	0.000219	0.000509	CcSEcCtD
Efavirenz—Rash—Dexamethasone—psoriatic arthritis	0.000219	0.000509	CcSEcCtD
Efavirenz—Dermatitis—Dexamethasone—psoriatic arthritis	0.000219	0.000508	CcSEcCtD
Efavirenz—Dermatitis—Betamethasone—psoriatic arthritis	0.000219	0.000508	CcSEcCtD
Efavirenz—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000219	0.000507	CcSEcCtD
Efavirenz—Fatigue—Methotrexate—psoriatic arthritis	0.000218	0.000506	CcSEcCtD
Efavirenz—Headache—Dexamethasone—psoriatic arthritis	0.000218	0.000505	CcSEcCtD
Efavirenz—Headache—Betamethasone—psoriatic arthritis	0.000218	0.000505	CcSEcCtD
Efavirenz—Asthenia—Prednisone—psoriatic arthritis	0.000217	0.000504	CcSEcCtD
Efavirenz—Pain—Methotrexate—psoriatic arthritis	0.000216	0.000502	CcSEcCtD
Efavirenz—Pruritus—Prednisone—psoriatic arthritis	0.000214	0.000497	CcSEcCtD
Efavirenz—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000209	0.000484	CcSEcCtD
Efavirenz—Diarrhoea—Prednisone—psoriatic arthritis	0.000207	0.000481	CcSEcCtD
Efavirenz—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000207	0.00048	CcSEcCtD
Efavirenz—Nausea—Dexamethasone—psoriatic arthritis	0.000207	0.000479	CcSEcCtD
Efavirenz—Nausea—Betamethasone—psoriatic arthritis	0.000207	0.000479	CcSEcCtD
Efavirenz—Urticaria—Methotrexate—psoriatic arthritis	0.000201	0.000466	CcSEcCtD
Efavirenz—Dizziness—Prednisone—psoriatic arthritis	0.0002	0.000465	CcSEcCtD
Efavirenz—Abdominal pain—Methotrexate—psoriatic arthritis	0.0002	0.000464	CcSEcCtD
Efavirenz—Body temperature increased—Methotrexate—psoriatic arthritis	0.0002	0.000464	CcSEcCtD
Efavirenz—Vomiting—Prednisone—psoriatic arthritis	0.000193	0.000447	CcSEcCtD
Efavirenz—Rash—Prednisone—psoriatic arthritis	0.000191	0.000443	CcSEcCtD
Efavirenz—Dermatitis—Prednisone—psoriatic arthritis	0.000191	0.000442	CcSEcCtD
Efavirenz—Headache—Prednisone—psoriatic arthritis	0.00019	0.00044	CcSEcCtD
Efavirenz—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000186	0.000433	CcSEcCtD
Efavirenz—Asthenia—Methotrexate—psoriatic arthritis	0.000182	0.000421	CcSEcCtD
Efavirenz—Nausea—Prednisone—psoriatic arthritis	0.00018	0.000417	CcSEcCtD
Efavirenz—Pruritus—Methotrexate—psoriatic arthritis	0.000179	0.000415	CcSEcCtD
Efavirenz—Diarrhoea—Methotrexate—psoriatic arthritis	0.000173	0.000402	CcSEcCtD
Efavirenz—Dizziness—Methotrexate—psoriatic arthritis	0.000167	0.000388	CcSEcCtD
Efavirenz—Vomiting—Methotrexate—psoriatic arthritis	0.000161	0.000373	CcSEcCtD
Efavirenz—Rash—Methotrexate—psoriatic arthritis	0.00016	0.00037	CcSEcCtD
Efavirenz—Dermatitis—Methotrexate—psoriatic arthritis	0.000159	0.00037	CcSEcCtD
Efavirenz—Headache—Methotrexate—psoriatic arthritis	0.000159	0.000368	CcSEcCtD
Efavirenz—Nausea—Methotrexate—psoriatic arthritis	0.00015	0.000349	CcSEcCtD
